Clinical Trial Update: Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Ad-TD-nsIL12, an oncolytic virus, in primary high-grade glioma, currently in Phase 1/Phase 2 and enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Drugs mentioned

• Ad-TD-nsIL12

Snippet

Sponsor: Xiaorong Wu | Conditions: Glioma | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION